Search

everythinglearnresearchcommunity

for

Search:↓

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Dermatological conditions are complex and treatments often have mixed results.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.